Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/329010

Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US

Description:

Urinary incontinence and overactive bladder disorders are estimated to affect more than 10% of the female population. However, presentation, diagnosis and treatments rates are poor. In the US, the employment of Continence Nurses provides an ideal opportunity to ensure that patients are able to gain access to expert advice and treatment.

Scope of this title:
- Assessment of the responsibilities of the US Continence Nurse including their role in the referral pathway, diagnosis and prescribing of drug therapy
- Evaluation of reasons influencing patient presentation including educational and marketing campaigns
- Analysis of treatment methods employed, influences on treatment choice and perception of current drug therapies
- Identification of unmet needs and potential drivers of change

Highlights of this title:
Continence Nurses in the US play a varied role in the management of urinary incontinence and overactive bladder patients, with over two thirds recommending or prescribing pharmacological therapies. Pharmaceutical companies promoting pharmacological therapies in the US should consider Continence Nurses as key targets.

For more than 50% of patients presenting to Continence Nurses, this is the first healthcare professional that the patient will have spoken to about their condition; frequently identified as a direct result of presenting for another condition. Therefore, Continence Nurses are vital to the diagnosis and referral of this subgroup of patients.

Continence Nurses are likely to have more time than other physicians to discuss the nature of symptoms and side effects with patients. By supporting Continence Nurses, pharmaceutical companies could improve patients knowledge of the condition and its treatment, thereby improving treatment retention and switching rates.

Reasons to order your copy:
- Understand the role of Continence Nurses in the treatment of urinary incontinence and overactive bladder for strategic product planning and targeting
- Evaluate methods for improving presentation rates and thereby utilization of treatments for urinary incontinence and overactive bladder disorders
- Identify concerns of Continence Nurses and patients regarding current treatment and unmet needs

Contents:

OVERVIEW
This product has been designed for delivery in a slide pack format (PowerPoint). 5
Please select the slide pack option from the download menu at the side of the page 5
Introduction 5
Scope of this report 5
Research and analysis highlights 6
Key reasons to read this report 6

APPENDIX A
Research methodology 7
Continence nurse questionnaire 7
Screening Information 7
Overview of the study 9
Section One epidemiology 10
Section Two Presentation and help seeking behavior 11
Section Three Diagnosis and management 16
Referral pattern 17
Section Four Treatment 20
Non-pharmacological treatment 22
Pharmacological treatment 23
Section Five General 24
Section A: Drug influences 24
Section B: The general treatment of urinary incontinence and overactive bladder 26
Contributing experts 29
US 29
Japan 29
Europe 30

APPENDIX B

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/329010

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 30/11/2009 01:37:17

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US
Web Address:
http://www.researchandmarkets.com/reports/329010
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		€1,276.00
Electronic - Enterprisewide		€3,190.00

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 30/11/2009 01:37:17

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)